ATE372126T1 - Spüllösung und verfahren zur schmerzlinderung und entzündungshemmung - Google Patents
Spüllösung und verfahren zur schmerzlinderung und entzündungshemmungInfo
- Publication number
- ATE372126T1 ATE372126T1 AT99956954T AT99956954T ATE372126T1 AT E372126 T1 ATE372126 T1 AT E372126T1 AT 99956954 T AT99956954 T AT 99956954T AT 99956954 T AT99956954 T AT 99956954T AT E372126 T1 ATE372126 T1 AT E372126T1
- Authority
- AT
- Austria
- Prior art keywords
- antagonist
- solution
- pain
- inflammation
- soluble receptor
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 3
- 239000005557 antagonist Substances 0.000 abstract 3
- 230000004054 inflammatory process Effects 0.000 abstract 3
- 206010052428 Wound Diseases 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 238000001356 surgical procedure Methods 0.000 abstract 2
- 229940127291 Calcium channel antagonist Drugs 0.000 abstract 1
- 229940122204 Cyclooxygenase inhibitor Drugs 0.000 abstract 1
- 102000016924 KATP Channels Human genes 0.000 abstract 1
- 108010053914 KATP Channels Proteins 0.000 abstract 1
- 102000000033 Purinergic Receptors Human genes 0.000 abstract 1
- 108010080192 Purinergic Receptors Proteins 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000000480 calcium channel blocker Substances 0.000 abstract 1
- BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 230000002262 irrigation Effects 0.000 abstract 1
- 238000003973 irrigation Methods 0.000 abstract 1
- 239000002756 mu opiate receptor agonist Substances 0.000 abstract 1
- 239000002742 neurokinin 1 receptor antagonist Substances 0.000 abstract 1
- 239000002746 neurokinin 2 receptor antagonist Substances 0.000 abstract 1
- 239000004036 potassium channel stimulating agent Substances 0.000 abstract 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 abstract 1
- 239000003215 serotonin 5-HT2 receptor antagonist Substances 0.000 abstract 1
- 239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 abstract 1
- 239000000952 serotonin receptor agonist Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10725698P | 1998-11-05 | 1998-11-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE372126T1 true ATE372126T1 (de) | 2007-09-15 |
Family
ID=22315706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99956954T ATE372126T1 (de) | 1998-11-05 | 1999-11-05 | Spüllösung und verfahren zur schmerzlinderung und entzündungshemmung |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1206275B1 (de) |
| AT (1) | ATE372126T1 (de) |
| AU (1) | AU1345000A (de) |
| DE (1) | DE69937070D1 (de) |
| WO (1) | WO2000025745A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7067144B2 (en) | 1998-10-20 | 2006-06-27 | Omeros Corporation | Compositions and methods for systemic inhibition of cartilage degradation |
| EP1200127B1 (de) * | 1999-07-21 | 2008-06-25 | Omeros Corporation | Spüllösungen und verfahren zur schmerzhemmung, entzündungshemmung und hemmung des knorpelabbaus |
| WO2003063799A2 (en) * | 2002-02-01 | 2003-08-07 | Omeros Corporation | Compositions and methods for systemic inhibition of cartilage degradation |
| SI1534313T1 (sl) | 2002-07-30 | 2013-03-29 | Omeros Corporation | Oftalmološke raztopine in postopek za izpiranje |
| GB0319500D0 (en) | 2003-08-19 | 2003-09-17 | Resolution Chemicals Ltd | Particle-size reduction apparatus,and use thereof |
| GB0427568D0 (en) | 2004-12-16 | 2005-01-19 | Resolution Chemicals Ltd | Particle-size reduction apparatus, and the use thereof |
| JP2010516734A (ja) | 2007-01-24 | 2010-05-20 | グラクソ グループ リミテッド | ３，５−ジアミノ−６−（２，３−ジクロロフェニル）−１，２，４−トリアジンまたはｒ（−）−２，４−ジアミノ−５−（２，３−ジクロロフェニル）−６−フルオロメチルピリミジンを含む医薬組成物 |
| AU2013201465B2 (en) | 2012-10-24 | 2016-03-03 | Rayner Intraocular Lenses Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
| TWI809304B (zh) | 2014-12-01 | 2023-07-21 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968607A (en) * | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
| US5350683A (en) * | 1990-06-05 | 1994-09-27 | Immunex Corporation | DNA encoding type II interleukin-1 receptors |
| JPH07504203A (ja) * | 1992-09-15 | 1995-05-11 | イミュネックス・コーポレーション | 腫瘍壊死因子アンタゴニストを用いるｔｎｆ−依存性炎症の治療方法 |
| US5844092A (en) * | 1994-03-18 | 1998-12-01 | Genentech, Inc. | Human TRK receptors and neurotrophic factor inhibitors |
| IT1274350B (it) * | 1994-12-06 | 1997-07-17 | Angeletti P Ist Richerche Bio | Antagonisti di interleuchina-6(il-6) che consistono di forme solubili del ricettore alfa di il-6, mutate nell'interfaccia che si lega a gp 130 |
| KR100517210B1 (ko) * | 1994-12-12 | 2006-06-07 | 오메로스 코포레이션 | 통증,염증및경련억제용관주용액 |
| IL112834A (en) * | 1995-03-01 | 2000-12-06 | Yeda Res & Dev | Pharmaceutical compositions for controlled release of soluble receptors |
-
1999
- 1999-11-05 DE DE69937070T patent/DE69937070D1/de not_active Expired - Lifetime
- 1999-11-05 AU AU13450/00A patent/AU1345000A/en not_active Abandoned
- 1999-11-05 WO PCT/US1999/026330 patent/WO2000025745A2/en not_active Ceased
- 1999-11-05 AT AT99956954T patent/ATE372126T1/de not_active IP Right Cessation
- 1999-11-05 EP EP99956954A patent/EP1206275B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69937070D1 (de) | 2007-10-18 |
| EP1206275A2 (de) | 2002-05-22 |
| EP1206275B1 (de) | 2007-09-05 |
| WO2000025745A3 (en) | 2000-08-24 |
| WO2000025745A2 (en) | 2000-05-11 |
| AU1345000A (en) | 2000-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02000721A (es) | Soluciones y metodos para la inhibicion del dolor, la inflamacion y la degradacion de cartilago. | |
| AU6397496A (en) | Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis | |
| ATE182792T1 (de) | Wundheilung | |
| CA2206119A1 (en) | Irrigation solution and method for inhibition of pain, inflammation and spasm | |
| PT646012E (pt) | Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3 | |
| NZ515567A (en) | Method for treating chronic pain using MEK inhibitors | |
| ATE227124T1 (de) | Behandlung von multipler sklerose (ms) und anderen demyelinisationserkrankungen unter verwendung von lofepramin in kombination mit l- phenylalamin, tyrosin oder tryptophan und evtl. einer vitamin b12-verbindung | |
| ES2166111T3 (es) | Uso de tiagabina para el tratamiento de trastornos del sueño. | |
| WO2000023062A3 (en) | Irrigation solution and method for inhibition of pain and inflammation | |
| ES2144119T3 (es) | Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada. | |
| EE200300095A (et) | Ravimi transdermaalse transpordi vähenemise pärssimise meetodid kanalite sulgumise pärssimisega | |
| PT1009425E (pt) | Cicatrizacao de feridas | |
| ATE372126T1 (de) | Spüllösung und verfahren zur schmerzlinderung und entzündungshemmung | |
| RU94044356A (ru) | Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с | |
| ATE413177T1 (de) | Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen | |
| DE69924536D1 (de) | Spülende lösung und methoden zur hemmung von schmerzen und entzündungen | |
| RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
| WO2000023061A3 (en) | Irrigation solution and method for inhibition of pain and inflammation | |
| SE9101840D0 (sv) | New medicinal use | |
| ID26965A (id) | Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid | |
| EP1563838A3 (de) | Spülende Lösung und Methoden zur Hemmung von Schmerzen und Entzündungen | |
| CZ223199A3 (cs) | Použití inhibitorů COMT nebo jejich farmaceuticky vhodných solí nebo esterů pro výrobu léčiva k prevenci diabetických vaskulárních dysfunkcí | |
| BR0014751A (pt) | Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto | |
| ATE306923T1 (de) | Verwendung von (e)-metanicotinederivate als analgetika | |
| BR0308105A (pt) | Composição farmacêutica compreendendo um bisfosfonato e um inibidor de cox-2 para o tratamento de doenças de ossos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |